GB1417119A - Process for treating bones - Google Patents
Process for treating bonesInfo
- Publication number
- GB1417119A GB1417119A GB5544472A GB5544472A GB1417119A GB 1417119 A GB1417119 A GB 1417119A GB 5544472 A GB5544472 A GB 5544472A GB 5544472 A GB5544472 A GB 5544472A GB 1417119 A GB1417119 A GB 1417119A
- Authority
- GB
- United Kingdom
- Prior art keywords
- fatty acid
- sodium
- acid
- bone fractures
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
1417119 Treating bone fractures G H THIELE 30 Nov 1972 55444/72 Heading ASB Bone fractures may be healed by local injection of a liquid of pH 8-11 comprising (a) a salt or ester of formic acid, an alkane carboxylic acid, an unsaturated fatty acid, a hydroxy-substituted fatty acid, a hydrogenated fatty acid or a polymerised fatty acid and (b) a liquid carrier. Salts specified include sodium morrhuate, ethylammonium oleate, sodium psyllicate and sodium ricinoleate. The carrier is usually water and may also contain ethanol, benzyl alcohol and sodium hydroxide. Where necessary, the bones are aligned before treatment and several doses of the composition may be administered over a period. The treatment is applied to the coffin 'bone of a horse.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5544472A GB1417119A (en) | 1972-11-30 | 1972-11-30 | Process for treating bones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5544472A GB1417119A (en) | 1972-11-30 | 1972-11-30 | Process for treating bones |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1417119A true GB1417119A (en) | 1975-12-10 |
Family
ID=10473924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5544472A Expired GB1417119A (en) | 1972-11-30 | 1972-11-30 | Process for treating bones |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1417119A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529081A1 (en) * | 1982-06-28 | 1983-12-30 | Mochida Pharm Co Ltd | THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
FR2573653A1 (en) * | 1984-11-23 | 1986-05-30 | Pf Medicament | Antiandrogen pharmaceutical compositions based on fatty acids |
EP0517425A1 (en) * | 1991-06-05 | 1992-12-09 | Efamol Holdings Plc | Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis |
EP0585026A1 (en) * | 1992-08-21 | 1994-03-02 | Scotia Holdings Plc | Use of fatty acids for increasing gut calcium absorption |
US5888541A (en) * | 1992-08-21 | 1999-03-30 | Scotia Holdings Plc | Fatty acid treatment |
-
1972
- 1972-11-30 GB GB5544472A patent/GB1417119A/en not_active Expired
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529081A1 (en) * | 1982-06-28 | 1983-12-30 | Mochida Pharm Co Ltd | THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
NL8302273A (en) * | 1982-06-28 | 1984-01-16 | Mochida Pharm Co Ltd | THERAPEUTIC PREPARATION FOR TREATING HEART DISEASE. |
US4578400A (en) * | 1982-06-28 | 1986-03-25 | Mochida Pharmaceutical Co., Ltd. | Therapeutic composition and method for treatment of cardiovascular diseases |
FR2573653A1 (en) * | 1984-11-23 | 1986-05-30 | Pf Medicament | Antiandrogen pharmaceutical compositions based on fatty acids |
EP0517425A1 (en) * | 1991-06-05 | 1992-12-09 | Efamol Holdings Plc | Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis |
US5318991A (en) * | 1991-06-05 | 1994-06-07 | Efamol Holdings Plc | Fatty acid treatment to reduce calcium excretion |
EP0585026A1 (en) * | 1992-08-21 | 1994-03-02 | Scotia Holdings Plc | Use of fatty acids for increasing gut calcium absorption |
US5618558A (en) * | 1992-08-21 | 1997-04-08 | Scotia Holdings Plc | Fatty acid treatment |
US5888541A (en) * | 1992-08-21 | 1999-03-30 | Scotia Holdings Plc | Fatty acid treatment |
SG80536A1 (en) * | 1992-08-21 | 2001-05-22 | Scotia Holdings Plc | Use of fatty acids for increasing gut calcium absorption |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1440386A (en) | Tratment of mosaic bone fractures of the bone and periosteum in non-human animals | |
ES2168334T3 (en) | COMPOSITION FOR SKIN TREATMENT. | |
BE878772A (en) | PROCESS FOR THE PREPARATION OF SILVER SALTS OF ORGANIC CARBOXYLIC ACIDS | |
US3741204A (en) | Method of trating bone fractures and non unions | |
GB1417119A (en) | Process for treating bones | |
US3805776A (en) | Treatment of non-surgical osteolysis of bone | |
CA945317A (en) | Vaporizing apparatus for treatment of animal carcasses | |
ES404748A1 (en) | Process for preparing injectionable compositions | |
FR1429208A (en) | Process for the preparation of alkali salts of carboxylic acids | |
SE7905659L (en) | MEANS FOR THE TREATMENT OF SEBORREIS CONDITIONS | |
ES388882A1 (en) | 1-(2'-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof | |
FR2390157A1 (en) | PRODUCT AND PROCESS FOR THE TREATMENT OF DENTAL IVORY WITH CERIUM | |
US3828772A (en) | Method of fusing bones | |
Freed et al. | Therapeutic use of estrone suspensions | |
US3767812A (en) | Non surgical removal of abnormal bone proliferation | |
ES344031A1 (en) | A PROCEDURE FOR PRODUCING A COMPOSITION OF DL-METHIO-NINE. | |
GB1452263A (en) | Amino acid process for its preparation and compositions thereof | |
ES8205787A1 (en) | 7-oxoprostacyclin derivatives and process for the preparation thereof. | |
SU733683A1 (en) | Antitrichomonas agent | |
ES8104214A1 (en) | Procedure for the obtaining of active therapeutic derivatives of the 2,5-dihydroxy-bencensulphonic acid. (Machine-translation by Google Translate, not legally binding) | |
ES465630A1 (en) | Tanning composition and process | |
AU6545580A (en) | Solutions of canrenoic acid and furosemide salts | |
GB882952A (en) | Process for preparing cyclohexylsulfamic acid and cyclohexylsulfamates | |
GB950498A (en) | Vaccine or antigen compositions | |
GB1384937A (en) | Method of producing gelatin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |